Company / Return on Assets (ROA)
Avidity Biosciences, Inc. Return on Assets (ROA) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-35.0%
FY2025
5-year range
-35.0% / -20.6%
FY2021-FY2025
Trend
-69.6%
vs FY2024
Sector context
#146 of 213
Health Care
What the data says
At -35.0%, Avidity Biosciences, Inc.'s return on assets (roa) ranks #146 of 213 in the Health Care sector. Return on Assets (ROA) has fluctuated over the past 7 years, ranging from -35.0% in FY2025 to -13.3% in FY2020.
Based on SEC 10-K filings.
-35.0% in FY2025 with a 5-year CAGR of -21.7%.
Declined from -33.8% to -35.0% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -7.7pp
- 5-Year Change
- -21.7pp
- 10-Year Change
- -
Sector benchmark
#146 of 213 in Health CareTop 69% of 213This company -35.0% Sector average -24.1%
▼
-44.8% below sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 69.6% year-over-year.
- Currently 10.8pp below the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -35.0% | -69.6% |
| FY2024 | -20.6% | +39.0% |
| FY2023 | -33.8% | -23.9% |
| FY2022 | -27.2% | +1.3% |
| FY2021 | -27.6% | -107.8% |
| FY2020 | -13.3% | +48.0% |
| FY2019 | -25.5% | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026